Rare bleeding disorder patients in India to get 1st preventive treatment

A US FDA-approved treatment that may prevent haemophilia, a rare bleeding disorder, has been launched in India for the first time, global biopharmaceutical company Takeda Pharmaceutical said on Monday.A genetic condition that prevents blood ...

Related Keywords

India ,New Delhi ,Delhi ,Sandeep Arora ,Head Of Medical Affairs ,Patient Services ,Takeda Pharmaceutical ,Medical Affairs ,Takeda India ,